PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.90%
Negative revenue growth while AR stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-35.05%
Negative gross profit growth while AR is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
507.34%
EBIT growth of 507.34% while AR is zero. Bruce Berkowitz would see if small gains can be scaled further.
507.34%
Operating income growth of 507.34% while AR is zero. Bruce Berkowitz would see if this modest edge can become significant.
104.88%
Net income growth of 104.88% while AR is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
105.99%
EPS growth of 105.99% while AR is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
105.99%
Diluted EPS growth of 105.99% while AR is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.41%
Negative OCF growth while AR is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-515.70%
Negative FCF growth while AR is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
198.69%
10Y CAGR of 198.69% while AR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-57.10%
Negative 5Y CAGR while AR stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-60.21%
Negative 3Y CAGR while AR stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
521.16%
OCF/share CAGR of 521.16% while AR is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-61.07%
Negative 5Y OCF/share CAGR while AR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-65.65%
Negative 3Y OCF/share CAGR while AR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-83.99%
Negative 10Y net income/share CAGR while AR is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-97.09%
Negative 5Y net income/share CAGR while AR is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-98.73%
Negative 3Y CAGR while AR is 0.00%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
264.25%
Equity/share CAGR of 264.25% while AR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-39.66%
Negative 5Y equity/share growth while AR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-63.04%
Negative 3Y equity/share growth while AR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
917.44%
Dividend/share CAGR of 917.44% while AR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
15.72%
Dividend/share CAGR of 15.72% while AR is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-50.06%
Negative near-term dividend growth while AR invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-2.77%
Firm’s AR is declining while AR shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Inventory is declining while AR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-31.54%
Negative asset growth while AR invests at 0.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-48.09%
We have a declining book value while AR shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-5.08%
We’re deleveraging while AR stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.